Evidence map›Paper›PMID 38001882›Full record

ReviewBiomedicines2023

An Overview of Recent Advances in the Neuroprotective Potentials of Fisetin against Diverse Insults in Neurological Diseases and the Underlying Signaling Pathways.

Xiangwen Tang, Peng Deng, Yizhen Jiang, Lingling Zhang, Yuqing He, Hao Yang

Open access · goldAbstract readReview
In one paragraph

Review in Biomedicines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Xiangwen TangTranslational Medicine Center, Hong Hui Hospital, Xi'an Jiaotong University, Xi'an 710054, China.
Peng DengBasic Medical School Academy, Shaanxi University of Traditional Chinese Medicine, Xianyang 712046, China.
Yizhen JiangBasic Medical School Academy, Shaanxi University of Traditional Chinese Medicine, Xianyang 712046, China.
Lingling ZhangTranslational Medicine Center, Hong Hui Hospital, Xi'an Jiaotong University, Xi'an 710054, China.
Yuqing HeSchool of Basic Medical Sciences, Ningxia Medical University, Yinchuan 750004, China.
Hao YangTranslational Medicine Center, Hong Hui Hospital, Xi'an Jiaotong University, Xi'an 710054, China.ORCID 0000-0002-1144-0584
Shaanxi University of Chinese Medicine · CNXi'an Honghui Hospital · CNNingxia Medical University · CNXi'an Jiaotong University · CN

Funding

key research and development program in Ningxia Hui Autonomous Region 2022BEG02032National Natural Science Foundation of China 82071551Natural Science Foundation of Shaanxi Province 2022JQ-755
6 · The paper itself

Abstract

The nervous system plays a leading role in the regulation of physiological functions and activities in the body. However, a variety of diseases related to the nervous system have a serious impact on human health. It is increasingly clear that neurological diseases are multifactorial pathological processes involving multiple cellular systems, and the onset of these diseases usually involves a diverse array of molecular mechanisms. Unfortunately, no effective therapy exists to slow down the progression or prevent the development of diseases only through the regulation of a single factor. To this end, it is pivotal to seek an ideal therapeutic approach for challenging the complicated pathological process to achieve effective treatment. In recent years, fisetin, a kind of flavonoid widely existing in fruits, vegetables and other plants, has shown numerous interesting biological activities with clinical potentials including anti-inflammatory, antioxidant and neurotrophic effects. In addition, fisetin has been reported to have diverse pharmacological properties and neuroprotective potentials against various neurological diseases. The neuroprotective effects were ascribed to its unique biological properties and multiple clinical pharmacological activities associated with the treatment of different neurological disorders. In this review, we summarize recent research progress regarding the neuroprotective potential of fisetin and the underlying signaling pathways of the treatment of several neurological diseases.

Indexed as

fisetinflavonoidnerve injuryneurological diseasesneuroprotection

Identifiers

PMID38001882
PMCPMC10669030
OpenAlexW4387903894

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.